rs1555611293
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000053867.8(GRN):c.1072C>T(p.Gln358Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000053867.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRN | NM_002087.4 | c.1072C>T | p.Gln358Ter | stop_gained | 10/13 | ENST00000053867.8 | NP_002078.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRN | ENST00000053867.8 | c.1072C>T | p.Gln358Ter | stop_gained | 10/13 | 1 | NM_002087.4 | ENSP00000053867 | P1 | |
GRN | ENST00000589265.5 | c.601C>T | p.Gln201Ter | stop_gained | 6/9 | 5 | ENSP00000467616 | |||
GRN | ENST00000586443.1 | c.514C>T | p.Gln172Ter | stop_gained | 5/7 | 3 | ENSP00000465673 | |||
GRN | ENST00000589923.1 | n.330C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461768Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 727194
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 23, 2021 | Observed in individual with frontotemporal lobar degeneration with TDP-43 inclusions (Chen-Plotkin et al., 2011); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016) This variant is associated with the following publications: (PMID: 29724592, 23742080, 25525159, 21482928) - |
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 05, 2017 | - - |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions;C3539123:Neuronal ceroid lipofuscinosis 11 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 07, 2022 | ClinVar contains an entry for this variant (Variation ID: 447470). This premature translational stop signal has been observed in individual(s) with GRN-related conditions (PMID: 21482928, 33980708). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln358*) in the GRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRN are known to be pathogenic (PMID: 16862116, 16950801, 22608501). For these reasons, this variant has been classified as Pathogenic. - |
GRN-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 26, 2024 | The GRN c.1072C>T variant is predicted to result in premature protein termination (p.Gln358*). This variant has been reported in an individual with frontotemporal lobar degeneration and an individual with primary progressive aphasia (Table 2, Chen-Plotkin et al. 2011. PubMed ID: 21482928; Table 2-2, Saracino et al. 2021. PubMed ID: 33980708). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in GRN are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at